Literature DB >> 22464846

Paroxysmal kinesigenic dyskinesia: cortical or non-cortical origin.

Teun W van Strien1, Anne-Fleur van Rootselaar, Anthony A J Hilgevoord, Wim H J P Linssen, Alexander J A Groffen, Marina A J Tijssen.   

Abstract

Paroxysmal kinesigenic dyskinesia (PKD) is characterized by involuntary dystonia and/or chorea triggered by a sudden movement. Cases are usually familial with an autosomal dominant inheritance. Hypotheses regarding the pathogenesis of PKD focus on the controversy whether PKD has a cortical or non-cortical origin. A combined familial trait of PKD and benign familial infantile seizures has been reported as the infantile convulsions and paroxysmal choreoathetosis (ICCA) syndrome. Here, we report a family diagnosed with ICCA syndrome with an Arg217STOP mutation. The index patient showed interictal EEG focal changes compatible with paroxysmal dystonic movements of his contralateral leg. This might support cortical involvement in PKD.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22464846     DOI: 10.1016/j.parkreldis.2012.03.006

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  3 in total

1.  Genetic and phenotypic heterogeneity in sporadic and familial forms of paroxysmal dyskinesia.

Authors:  Alexander J A Groffen; Thom Klapwijk; Anne-Fleur van Rootselaar; Justus L Groen; Marina A J Tijssen
Journal:  J Neurol       Date:  2012-06-30       Impact factor: 4.849

2.  Association between clinical factors and orofacial dyskinesias in anti-N-methyl-D-aspartate receptor encephalitis.

Authors:  Hailun Hang; Liuyu Lin; Danhui Li; Jin Li; Jingping Shi; Jie Lu
Journal:  Brain Behav       Date:  2022-05-27       Impact factor: 3.405

3.  Phenotypes and PRRT2 mutations in Chinese families with benign familial infantile epilepsy and infantile convulsions with paroxysmal choreoathetosis.

Authors:  Xiaoling Yang; Yuehua Zhang; Xiaojing Xu; Shuang Wang; Zhixian Yang; Ye Wu; Xiaoyan Liu; Xiru Wu
Journal:  BMC Neurol       Date:  2013-12-26       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.